Rexahn Corporation
Records under this name other than patents Rexahn Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Rexahn Corporation
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,405,214 | Nucleoside derivatives and therapeutic use thereof Formerly held Term ended Term ended Aug 24, 2025 · From the USPTO record | Term ended | Term ended Aug 24, 2025 | From the USPTO record |
| US 7,205,283 | Antisense oligonucleotides that inhibit expression of HIF-1 Formerly held Term ended Term ended Jun 16, 2025 · From the USPTO record | Term ended | Term ended Jun 16, 2025 | From the USPTO record |
| US 7,122,527 | Use of antisense oligonucleotides to inhibit the expression of human Akt-1 Formerly held Term ended Term ended Feb 10, 2025 · From the USPTO record | Term ended | Term ended Feb 10, 2025 | From the USPTO record |